Related Experiment Video
Updated: Aug 26, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation
Asa B Gustafsson1, Joseph G Tsai, Susan E Logue
1Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.
Abstract:
Myocardial ischemia/reperfusion (I/R) is associated with an extensive loss of myocardial cells. The apoptosis repressor with caspase recruitment domain (ARC) is a protein that is highly expressed in heart and skeletal muscle and has been demonstrated to protect the heart against I/R injury (Gustafsson, A. B., Sayen, M. R., Williams, S. D., Crow, M. T., and Gottlieb, R. A. (2002) Circulation 106, 735-739). In this study, we have shown that transduction of TAT-ARCL31F, a mutant of ARC in the caspase recruitment domain, did not reduce creatine kinase release and infarct size after I/R. TAT-ARCL31F also failed to protect against hydrogen peroxide-mediated cell death in H9c2 cells, suggesting that the caspase recruitment domain is important in mediating ARC's protective effects. In addition, we report that ARC co-immunoprecipitated with the pro-apoptotic protein Bax, which causes cytochrome c release when activated. TAT-ARC, but not TAT-ARCL31F, prevented Bax activation and cytochrome c release in hydrogen peroxide-treated H9c2 cells. TAT-ARC was also effective in blocking cytochrome c release after ischemia and reperfusion, whereas TAT-ARCL31F had no effect on cytochrome c release. In addition, recombinant ARC protein abrogated Bax-induced cytochrome c release from isolated mitochondria. This suggests that ARC can protect against cell death by interfering with activation of the mitochondrial death pathway through the interaction with Bax, preventing mitochondrial dysfunction and release of pro-apoptotic factors.
Insights
The apoptosis repressor with caspase recruitment domain (ARC) protects the heart from injury. A mutant ARC protein lacking a functional caspase recruitment domain failed to prevent cell death, indicating this domain is crucial for ARC
Area of Science:
- Cardiovascular Biology
- Cell Death Mechanisms
- Molecular Cardiology
Background:
- Myocardial ischemia/reperfusion (I/R) injury causes significant heart cell loss.
- Apoptosis repressor with caspase recruitment domain (ARC) is a cardioprotective protein highly expressed in cardiac muscle.
- The role of ARC's caspase recruitment domain (CARD) in I/R injury protection is not fully understood.
Purpose of the Study:
- To investigate the role of ARC's CARD in mediating protection against myocardial I/R injury.
- To determine if ARC interacts with pro-apoptotic proteins like Bax to regulate cell death pathways.
Main Methods:
- Utilized a mutant ARC (TAT-ARCL31F) lacking CARD function in I/R injury models.
- Assessed cell death and cardiac damage markers (creatine kinase, infarct size).
- Examined ARC's interaction with Bax and its effect on cytochrome c release in vitro and in vivo.
Main Results:
- TAT-ARCL31F did not reduce infarct size or creatine kinase release post-I/R.
- The mutant ARC failed to protect H9c2 cells from hydrogen peroxide-induced death.
- ARC co-immunoprecipitated with Bax, and TAT-ARC prevented Bax activation and cytochrome c release, unlike TAT-ARCL31F.
Conclusions:
- The CARD of ARC is essential for its protective effects against I/R injury.
- ARC protects the heart by inhibiting the mitochondrial death pathway through interaction with Bax.
- Targeting ARC may offer a therapeutic strategy for mitigating I/R-induced myocardial damage.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
The Extrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy

